MedTrace Logo

Sleep Apnea and Tromboembolic Disease

NCT00501358 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2007-07-16

No results posted yet for this study

Summary

There is some evidence for a hypercoagulable state in sleep apnea-hipopnea syndrome (SAHS), which could play a role in the increased cardiovascular morbility and mortality. Respiratory alterations (hypoxia, hypoxia- reoxygenation) and sleep fragmentation that these patients suffer during the sleep may induce modifications in clotting-fibrinolisis factors that may be a risk factor for venous thromboembolism (VTE).

OBJECTIVES:To calculate and compare the prevalence of sleep apnea-hipopnea syndrome in patients with venous thromboembolism with a gender, aged and BMI matched control group. Assessment of the association between SAHS and other risk factors for VTE. To compare clotting- fibrinolisis patterns, sleep parameters, blood pressure and pulmonary arterial obstruction index in patients with SAHS and VTE and those ones without SAHS.

Conditions

  • Sleep Apnea Syndromes
  • Venous Thromboembolism

Sponsors & Collaborators

  • Fundacion Caubet-Cimera Islas Baleares

    collaborator OTHER

  • Sociedad Española de Neumología y Cirugía Torácica

    lead OTHER

Principal Investigators

  • Alberto Alonso, MD · Sociedad Española de Neumología y Cirugía Torácica

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501358 on ClinicalTrials.gov